Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.66 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KDM5A | P29375 | 1/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.47 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 6/20 | 0.45 |
| ▸ | PPARD | Q03181 | 6/20 | 0.45 |
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25702799 | 1.00 | CNR1 (0.66) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| SCHEMBL1982755 | 1.00 | CNR1 (0.66) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| SCHEMBL5195516 | 1.00 | CNR1 (0.66) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| SCHEMBL5192446 | 1.00 | CNR1 (0.66) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| SCHEMBL6852352 | 1.00 | CNR1 (0.66) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| SCHEMBL1498623 | 1.00 | CNR1 (0.66) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| Sulfuric Acid SCHEMBL31710598 | 0.93 | CNR1 (0.59) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| Sulfuric Acid SCHEMBL31710161 | 0.93 | CNR1 (0.59) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| SCHEMBL20725634 | 0.92 | CNR1 (0.54) | CNR1EPHX2ALDH1A1KDM5AKDM4C | |
| SCHEMBL822981 | 0.92 | CNR1 (0.54) | CNR1EPHX2ALDH1A1KDM5AKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193137-B2 | Thickening composition | AJINOMOTO CO., INC. (JP) | 2012-06-05 | — | — | US | claimed |
| US-20240016953-A1 | TARGETED DELIVERY OF NICOTINAMINDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIBITORS | SEAGEN INC (US) | 2024-01-18 | — | — | US | disclosed |
| WO-2023114937-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2023-06-22 | — | — | WO | disclosed |
| WO-2021030701-A1 | IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS | Acuitas Therapeutics, Inc. (CA) | 2021-02-18 | — | — | WO | disclosed |
| EP-1746141-B1 | THICKENED CLEANSING COMPOSITIONS | AJINOMOTO KK (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-8193137-B2 | Thickening composition | AJINOMOTO CO., INC. (JP) | 2012-06-05 | — | — | US | disclosed |
| US-20110152148-A1 | THICKENING COMPOSITION | AJINOMOTO CO., INC (JP) | 2011-06-23 | — | — | US | disclosed |
| WO-2011032924-A1 | ANTIMICROBIAL 2-HYDROXYETHYL AMIDE | EVONIK GOLDSCHMIDT GMBH (DE) | 2011-03-24 | — | — | WO | disclosed |
| US-20100292115-A1 | THICKENING COMPOSITION | AJINOMOTO CO. INC (JP) | 2010-11-18 | — | — | US | disclosed |
| US-20070037728-A1 | Thickening composition | AJINOMOTO CO. INC (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1746141-A1 | THICKENING COMPOSITION | Ajinomoto Co., Inc. (JP) | 2007-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016953-A1 | TARGETED DELIVERY OF NICOTINAMINDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIBITORS | NAMPT, NAPRT, NNMT | CNR1 2228/4885EPHX2 2307/4885ALDH1A1 2101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.